BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33485619)

  • 1. Impact of cancer center accreditation on outcomes of patients undergoing resection for hepatocellular carcinoma: A SEER-Medicare analysis.
    Tsilimigras DI; Hyer JM; Diaz A; Moris D; Abbas A; Dillhoff M; Cloyd JM; Ejaz A; Beane JD; Tsung A; Pawlik TM
    Am J Surg; 2021 Sep; 222(3):570-576. PubMed ID: 33485619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in long-term oncologic outcomes by type of cancer center accreditation: An analysis of a SEER-Medicare population with pancreatic cancer.
    Fong ZV; Chang DC; Hur C; Jin G; Tramontano A; Sell NM; Warshaw AL; Fernandez-Del Castillo C; Ferrone CR; Lillemoe KD; Qadan M
    Am J Surg; 2020 Jul; 220(1):29-34. PubMed ID: 32265013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to Accredited Cancer Hospitals Within Federal Exchange Plans Under the Affordable Care Act.
    Kehl KL; Liao KP; Krause TM; Giordano SH
    J Clin Oncol; 2017 Feb; 35(6):645-651. PubMed ID: 28068172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Dedicated Cancer Centers on Outcomes Among Medicare Beneficiaries Undergoing Liver and Pancreatic Cancer Surgery.
    Mehta R; Ejaz A; Hyer JM; Tsilimigras DI; White S; Merath K; Sahara K; Bagante F; Paredes AZ; Cloyd JM; Dillhoff M; Tsung A; Pawlik TM
    Ann Surg Oncol; 2019 Nov; 26(12):4083-4090. PubMed ID: 31376033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between cancer center accreditation and performance on publicly reported quality measures.
    Merkow RP; Chung JW; Paruch JL; Bentrem DJ; Bilimoria KY
    Ann Surg; 2014 Jun; 259(6):1091-7. PubMed ID: 24509202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dedicated Cancer Centers are More Likely to Achieve a Textbook Outcome Following Hepatopancreatic Surgery.
    Mehta R; Tsilimigras DI; Paredes AZ; Sahara K; Dillhoff M; Cloyd JM; Ejaz A; White S; Pawlik TM
    Ann Surg Oncol; 2020 Jun; 27(6):1889-1897. PubMed ID: 32108924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after resection of alcohol-related versus hepatitis-related hepatocellular carcinoma: A SEER-Medicare database analysis.
    Mehta R; Tang Qinghe ; Tsilimigras DI; Paredes A; Dillhoff M; Cloyd JM; Ejaz A; Tsung A; Spolverato G; Pawlik TM
    Am J Surg; 2021 Jul; 222(1):167-172. PubMed ID: 33131693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do cancer centers designated by the National Cancer Institute have better surgical outcomes?
    Birkmeyer NJ; Goodney PP; Stukel TA; Hillner BE; Birkmeyer JD
    Cancer; 2005 Feb; 103(3):435-41. PubMed ID: 15622523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence.
    In H; Neville BA; Lipsitz SR; Corso KA; Weeks JC; Greenberg CC
    Ann Surg; 2012 May; 255(5):890-5. PubMed ID: 22504278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.
    Chapman BC; Paniccia A; Hosokawa PW; Henderson WG; Overbey DM; Messersmith W; McCarter MD; Gleisner A; Edil BH; Schulick RD; Gajdos C
    J Am Coll Surg; 2017 Mar; 224(3):362-372. PubMed ID: 27923615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Cancer Institute designation predicts improved outcomes in colorectal cancer surgery.
    Paulson EC; Mitra N; Sonnad S; Armstrong K; Wirtalla C; Kelz RR; Mahmoud NN
    Ann Surg; 2008 Oct; 248(4):675-86. PubMed ID: 18936581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
    Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
    J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes of liver transplantation versus liver resection among patients with hepatocellular carcinoma: A SEER-based longitudinal study.
    Zhang K; Chen R; Gong X; Gao Y
    J Formos Med Assoc; 2019 Apr; 118(4):790-796. PubMed ID: 30482570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Uhlig J; Sellers CM; Stein SM; Kim HS
    Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of national hospital accreditation in bariatric surgery on perioperative outcomes and long-term mortality.
    Telem DA; Talamini M; Altieri M; Yang J; Zhang Q; Pryor AD
    Surg Obes Relat Dis; 2015; 11(4):749-57. PubMed ID: 26001555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare.
    Shaya FT; Breunig IM; Seal B; Mullins CD; Chirikov VV; Hanna N
    Pharmacoeconomics; 2014 Jan; 32(1):63-74. PubMed ID: 24293197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Discharge Disposition Following Hepatectomy for Hepatocellular Carcinoma Among Medicare Beneficiaries.
    Dalmacy DM; Hyer JM; Diaz A; Paro A; Tsilimigras DI; Pawlik TM
    J Gastrointest Surg; 2021 Nov; 25(11):2842-2850. PubMed ID: 33821414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare.
    Zhang X; El-Serag HB; Thrift AP
    Cancer Causes Control; 2021 Apr; 32(4):317-325. PubMed ID: 33394207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative imaging surveillance for hepatocellular carcinoma: How much is enough?
    Mirdad RS; Madison Hyer J; Diaz A; Tsilimigras DI; Azap RA; Paro A; Pawlik TM
    J Surg Oncol; 2021 Jun; 123(7):1568-1577. PubMed ID: 33596330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis.
    Nathan H; Hyder O; Mayo SC; Hirose K; Wolfgang CL; Choti MA; Pawlik TM
    Ann Surg; 2013 Dec; 258(6):1022-7. PubMed ID: 23299519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.